Potential kidney cancer test in development
A Swedish biotechnology company, Elypta, has recently been awarded an [...]
Second-line treatment with axitinib in favourable risk patients
Results from a phase 2 study to assess the activity [...]
Real world safety and efficacy of nivolumab for kidney cancer
A recent study reports the real-world safety and efficacy of [...]
World Cancer Day
Today (4th February) is World Cancer Day, and KCSN are [...]
Biopsy of small renal massess
The question as to whether to biopsy small renal masses [...]
Stereotactic radiosurgery for multiple kidney cancer brain metastases
A recent study published in Clinical Genitourinary Cancer has shown that [...]
Immunoscore system to predict kidney cancer patient outcomes
A recent study by researchers in China, and published in [...]
Surgery may not be the most appropriate frontline treatment for metastatic kidney cancer
Results of the phase 3 SURTIME trial comparing pretreatment with [...]
New prognostic factor for metastatic renal cell carcinoma
A retrospective study has shown that a high systemic immune-inflammation [...]
ESOU 2019: Adjuvant therapy after nephrectomy for high-risk renal cell carcinoma
The following presentations were given at the European Association of [...]
